Clinical Trial Update: Perioperative Treatment With Tranexamic Acid in Melanoma [Phase 3]

View source ↗

Summary

This document details a Phase 3 clinical trial evaluating perioperative tranexamic acid in patients with melanoma that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Aarhus | Conditions: Melanoma | Phase 3 | Status: RECRUITING